@ncyrobles

Nurse Practitioner, specializing in inherited cardiovascular disease and advanced heart failure. Hablo Español.

 San Francisco, CA
Joined February 2016
  • Tweets97
  • Following521
  • Followers100
2Media
Observing a drug's journey from development to implementation has been a remarkable experience. #HCM #SCICD frontiersin.org/journals/car…

Frontiers | One-year real-world experience with mavacamten and its physiologic effects on obstruc...

Mavacamten is a first-in-class cardiac myosin ATPase inhibitor, approved by the United States Food and Drug Administration for the treatment of hypertrophic ...

frontiersin.org
102
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction. stan.md/4hPNhe5

Five things to know about GLP-1s and addiction

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

med.stanford.edu
3
12
29
3,958
Join me and the one and only, the legend, @cindyluzy at the 2025 MyHeartCounts 5k! Every step you take supports research and access for families affected by genetic heart disease. !🧬🏃🏻‍♀️♥️👩🏻‍🔬 #MyHeartCounts #stanfordhealthcare REGISTER HERE classy.org/event/my-heart-co…
1
2
600
Happy ❤️Month! Join me and @alyelezaby at the Stanford Medicine My Heart Counts 5K, kids fun run and cycling event to support families with 🫀disease! Myheartcountsrun.org youtube.com/watch?v=WVRbqX9_…
4
1
12
1,671
Nancy Robles retweeted
euan ashley@euanashley26 Jan 2025
Thanks to Sports Illustrated for featuring our work on the molecular adaptations to exercise!
1
4
35
1,914
Nancy Robles retweeted
euan ashley@euanashley23 Jan 2025
Come join us for the annual My Heart Counts walk-run around Stanford campus! Raise money for an amazing cause!
Victoria Parikh, MD@vnparikh22 Jan 2025
It's that time of year again! The Stanford Center for Inherited Cardiovascular Disease is raising funds for families with genetic heart disease with our annual fun run. I'll be there and I hope you will too! Sign up or donate here: classy.org/event/my-heart-co…
2
7
1,295
We are just so thrilled to launch our new center website! Check out all the cool stuff we're doing in CV genetics at the Stanford Center for Inherited Cardiovascular Disease (#SCICD): med.stanford.edu/familyheart…
1
9
50
2,484
We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley @euanashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.
38
33
17
314
68,178
The Stanford Center for Inherited Cardiovascular Disease (SCICD) is putting on our annual fundraising 5K! Please consider running or donating to support these brave families through out research and patient care. raceroster.com/events/2024/8…

Donate to help SCICD Team raise money for 2024 Stanford Medicine My Heart Counts 5K and Kids Fun...

Your donation will make a difference in a patient’s life. Will you RUN with the SCICD Center on April 21st?

raceroster.com
2
11
1
30
3,556
events.zoom.us/ev/Aj0rH7FJ5W…

Hypertrophic Cardiomyopathy Connection Forum

Can't join the full event? Attend as many or few sessions as your schedule allows.

events.zoom.us
28
Nancy Robles retweeted
euan ashley@euanashley1 Mar 2023
Nice feature on the bench to bedside story that is myosin inhibition for hypertrophic cardiomyopathy - a game changing therapeutic approach! scopeblog.stanford.edu/2023/…
2
14
1,109
Last but not least: Dr. @tikuowens will be presenting NEXT WEEK, May 18 from 12-1pm Pacific Time. The topic is a timely one: Cardiac Myosin Inhibitors for Treatment of HCM. Register here: bit.ly/3sO0lKD (cat 1 CEUs available #gcchat)
2
4
1
4
Nancy Robles retweeted
euan ashley@euanashley29 Apr 2022
A landmark day for patients with hypertrophic cardiomyopathy! The story began with basic insights into myosin biology from Jim Spudich @Stanford Rapid biotech development at Myokardia led to successful Phase 1-3 (first patient dosed at Stanford!). endpts.com/bristol-myers-cel…

Bristol Myers celebrates a big win with FDA approval of $13B cardio drug mavacamten

After getting hit with an FDA delay back in November, Bristol Myers Squibb is finally celebrating a win for mavacamten, the centerpiece of the company’s $13 billion MyoKardia buyout back ...

endpoints.news
1
3
21
Excited to see #mavacamten approval for patients with symptomatic obstructive hypertrophic cardiomyopathy! Spudich lab @stanford fundamental biophysics facilitating MyoKardia small molecule, trials @StanfordMed since 2015 - SAD, EXPLORER, VALOR, MAVA-LTE…more work to be done 1/4
2
9
1
60
#MEDIA: Announcing #FDA approval of first-in-class treatment for adults living with symptomatic NYHA class II-III obstructive hypertrophic cardiomyopathy (symptomatic obstructive #HCM). Learn more: bit.ly/3EVnkIt
4
33
5
82
Nancy Robles retweeted
euan ashley@euanashley31 Mar 2022
Tour. De. Force.
Adam Phillippy@aphillippy31 Mar 2022
Today is the big day! The #T2T consortium is claiming victory and announcing that we have finally uncovered every last bit of the human genome! The papers are out today 🥳🧬 science.org/toc/science/376/…
1
4
25
Congrats to rising star @ADevareddyMD @StanfordMedRes for presenting our results analyzing progression of disease in the pre-#mavacamten era using serial CPET testing in #HCM patients @StanfordMed #ACC22 @euanashley @jwc14 @Ron_Witteles
1
6
1
31
Nancy Robles retweeted
euan ashley@euanashley15 Feb 2022
Our annual 5k/10k/fun run is coming up for those in the Bay area. Please join us and support a great cause! myheartcountsrun.org/
1
4
8
SCICD’s new virtual DCM/HCM patient support group launches February 7th 6pm PST! Clinical psychologist Dr. Valerie Hoover will guide a conversation about living well with heart disease. Register to join: stanford.zoom.us/webinar/reg…
1
7
1
18
Load more